Los Altos, CA, United States of America

Jürg Pfister


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jürg Pfister: Innovator in Cardiovascular Treatments

Introduction

Jürg Pfister is a notable inventor based in Los Altos, California. He has made significant contributions to the field of cardiovascular medicine, particularly through his innovative patents. With a total of three patents to his name, Pfister's work focuses on the treatment of hypertension and angina.

Latest Patents

One of Pfister's latest patents is titled "Materials and methods for the treatment of hypertension and angina." This invention provides novel calcium channel blockers based on mibefradil. It also outlines methods for synthesizing these compounds. Furthermore, the invention offers methods for controlling or preventing hypertension, angina pectoris, ischemia, arrhythmias, and cardiac insufficiency in patients by administering the compounds or compositions developed.

Another significant patent is "Quinazoline derivatives as alpha-1 adrenergic antagonists." This work further showcases Pfister's dedication to advancing medical treatments.

Career Highlights

Throughout his career, Jürg Pfister has worked with several prominent companies, including Aryx Therapeutics, Inc. and Syntex (U.S.A.) Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Pfister has collaborated with notable professionals in his field, including Pascal Jean Druzgala and Peter G. Milner. These partnerships have likely enhanced his research and development efforts.

Conclusion

Jürg Pfister's contributions to cardiovascular treatments through his patents demonstrate his commitment to improving patient care. His innovative approaches continue to influence the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…